Aarhus N

• A study to test the effect of chemotherapy before surgery compared to surgery alone in patients with high risk retroperitoneal sarcoma. Recruiting
  2023-505261-84-00 5 2020-10-06 Primary high risk leiomyosarcoma or liposarcoma of retroperitoneal spa
• A clinical study of belzutifan and zanzalintinib in people with advanced kidney cancer (MK-6482-034) Recruiting
  2024-516993-31-00 5 2026-05-11 Renal Cell Carcinoma
• A clinical trial to find out how well LOU064 (remibrutinib) works and how safe it is for people with secondary progressive multiple sclerosi … Recruiting
  2025-521546-23-00 5 2026-04-21 Secondary progressive multiple sclerosis
• Steroid treatment in patients with heart attack - PULSE-MI 2 Recruiting
  2025-524320-21-00 5 2026-04-20 ST-segment Elevation Myocardial Infarction
• AMAZE 5: A research study investigating how well the medicine NNC0487-0111 helps people with excess body weight and knee osteoarthritis lose … Recruiting
  2024-520444-42-00 5 2026-04-15 Overweight or obesity, and knee osteoarthritis
• AMAZE 6: A research study investigating how well the medicine NNC0487-0111 helps people with excess body weight and knee osteoarthritis lose … Recruiting
  2024-520445-23-00 5 2026-04-15 Overweight or obesity, and knee osteoarthritis
• Up-titration of sulfonylurea (SU) in individuals with HNF1A- and HNF4A-MODY – A Steno MODERN-MODY project (MM-SUUP) Recruiting
  2025-524679-22-00 4 2026-04-14 Maturity-onset diabetes of the young type 3 (HNF1A-MODY)
• A Phase 3 Study to Evaluate AOC 1020 in Participants with FSHD Recruiting
  2025-521012-18-00 5 2026-04-13 Facioscapulohumeral Muscular Dystrophy (FSHD)
• Understanding the effect of CagriSema, cagrilintide, and semaglutide on muscle health Recruiting
  2025-522920-28-00 3 2026-04-10 Obesity, CCI, CCI
• A Randomized, placebo-controlled, double-blinded Phase 2 Trial of Dapagliflozin for Preventing Treatment-associated Cardiotoxicity in Lympho … Recruiting
  2025-521205-41-00 4 2026-03-12 Diffuse large B-cell lymphoma NOS, follicular lymphoma Grade 3b, anapl
• Prevention of Recurrent C. difficile Infection Study with AZD5148 Monoclonal Antibody Recruiting
  2025-521416-19-00 4 2026-03-12 Recurrence of Clostridioides difficile Infection
• Impact of Early Thyroid Hormone Replacement on Kidney Function and Health-Related Quality of Life in Patients at Risk of Postoperative Hypot … Recruiting
  2025-524175-23-00 6 2026-03-12 Hypothyroidism
• OCEAN(a)-CCTA - Olpasiran trials of Cardiovascular Events And LipoproteiN(a) reduction -Coronary Computed Tomography Angiography trial Recruiting
  2025-521117-88-00 5 2026-03-11 Cardiovascular Disease
• COMPARISON OF ZINC ACETATE DOSE REGIMENS (GALZIN VS. ET-700) FOR THE TREATMENT OF WILSON DISEASE: A PHARMACODYNAMIC 64CUCL2 PET/CT STUDY IN … Recruiting
  2025-523372-24-00 4 2026-03-10 Wilson's Disease
• The REVERT-PREDIABETES trial Recruiting
  2025-522970-35-00 11 2026-03-03 Coronary artery disease
• Early-stage clinical trial investigating the individual and combined effect of two drugs, senicapoc and perampanel, as part of the treatment … Recruiting
  2025-522605-37-00 3 2026-03-01 Glioblastoma
• Inhibiting BCL-2 at the start of HIV treatment to reduce the HIV reservoir in people living with HIV Recruiting
  2025-521841-26-00 9 2026-02-20 HIV-1 infection
• First-in-human (FIH) Trial of GEN3018 in Relapsed or Refractory (R/R) Acute Myeloid Leukemia (AML) or Higher-risk Myelodysplastic Syndrome ( … Recruiting
  2025-523101-15-00 1 2026-02-16 Relapsed or Refractory Acute Myeloid Leukemia or Higher-Risk Myelodysp
• A phase 2, randomized, double-blind study of S-606001 as an add-on to enzyme replacement therapy in patients with late-onset Pompe disease. Recruiting
  2025-522146-40-00 4 2026-02-12 Late-onset Pompe disease.
• The DALBA-study Introduction of the antibiotic dalbavancin in orthopaedic surgery – an evaluation of: • Health economic costs • Patient-repo … Recruiting
  2025-522088-13-00 6 2025-12-12 Periprosthetic joint infection
• A clinical study of belzutifan and zanzalintinib in people with advanced kidney cancer (MK-6482-033) Recruiting
  2024-517136-21-00 5 2025-12-05 Renal Cell Carcinoma
• A Study to Learn About the Study Medicine Called PF-08046054/SGNPDL1V Versus Docetaxel in Adult Participants with Previously-treated Program … Recruiting
  2025-521281-97-00 5 2025-12-02 Non-Small Cell Lung Cancer (NSCLC)
• A Study in TKI-naive Patients With Advanced ALK-Positive NSCLC ( ALKAZAR ) Recruiting
  2024-517553-26-00 5 2025-11-12 Advanced ALK-positive non-small cell lung cancer (NSCLC)
• A Efficacy and Safety Study of Trontinemab in Participants With Early Symptomatic Alzheimer’s Disease (MCI to Mild Dementia Due to AD) Recruiting
  2024-518008-33-00 5 2025-11-12 Early Symptomatic Alzheimer’s Disease (MCI to Mild Dementia due to AD)

Showing 97–120 of 582 trials